Insiders Biostax Corp.

Equities

Delayed OTC Markets Other stock markets 09:03:59 03/06/2024 pm IST			5-day change	1st Jan Change
0.0425 ^USD	+21.40%		+28.79%	-41.78%

20/05	Biostax Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
16/04	Biostax Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Biostax Corp. Appoints Craig Suro as a Director	15/11	CI
Biostax Corp. Appoints Mary Clay Caperton to its Board of Directors	02/11	CI
Immune Therapeutics, Inc. will Change its Name to Biostax Corp	05/23/05	CI
Immune Therapeutics, Inc. Announces CEO Changes	14/23/14	CI
Immune Therapeutics, Inc. Announces Management Changes	14/23/14	CI
Immune Therapeutics, Inc. Announces Director Resignations	04/23/04	CI
Immune Therapeutics, Inc. Announces Executive Changes	10/22/10	CI
Immune Therapeutics, Inc. Announces CEO Changes	10/22/10	CI
Immune Therapeutics, Inc. Appoints H. Louis Salomonksy to Its Board of Directors	28/22/28	CI
Immune Therapeutics, Inc. Announces the Appointment of Glen Farmer as Chief Financial Officer	04/22/04	CI
Immune Therapeutics, Inc. Announces the Appointment of Kelly O’Brien Wilson as Chief Operating Officer	04/22/04	CI
Immune Therapeutics, Inc. Announces Executive Changes	23/22/23	CI
Immune Therapeutics, Inc. Announces Chief Executive Officer Changes	23/22/23	CI
Immune Therapeutics, Inc. Announces Board Changes	04/22/04	CI
Immune Therapeutics, Inc. Announces the Resignation of Michael Sander as a Director	27/21/27	CI
Immune Therapeutics, Inc. Appoints Kevin J. Phelps as CEO	28/20/28	CI
Immune Therapeutics, Inc. Appoints Kevin J. Phelps as President	28/20/28	CI
Immune Therapeutics, Inc. Announces Management Changes	06/20/06	CI
Immune Therapeutics, Inc. Announces Executive Changes	18/20/18	CI
Immune Therapeutics, Inc. Appoints Dr. Robert Buckheit, Jr. to the Scientific Advisory Board	22/19/22	CI

No results for this search